LeadArt Biotechnologies Inc., founded in 2017. LeadArt is the first biotechnology company in China and one of the few in the world that has mastered breakthrough chemical proteomics technology. The company also has mature biotechnology automation equipment development and proven productization capabilities. Powered with state-of-art biotechnology and advanced automation technology, LeadArt is building the largest and leading live cell target-probe database in the world and aspired to expand the drug target space and speed up drug discovery.
LeadArt is a leading chemoproteomics and automation platform, and we have established multiple business and collaborations with universities, research institutes, biotech, biopharma, and medical companies.